COLLEEN JENNINGS: Open Payments
NPI 1942771001 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 14 payments from 9 companies in 2025. Trend: 2023 $614 · 2024 $362 · 2025 $610
Food & beverage: $350Consulting: $175Education: $86
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $175 |
| SOBI, INC | 2 | $106 |
| SANOFI-AVENTIS U.S. LLC | 4 | $105 |
| Amgen Inc. | 1 | $98 |
| GENZYME CORPORATION | 2 | $39 |
| Astellas Pharma US Inc | 1 | $30 |
| Incyte Corporation | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: ULTOMIRIS, REZUROCK, BLINCYTO, SARCLISA, Cresemba, NIKTIMVO, Doptelet, TALVEY.
Industry payments across PA — which companies pay providers there.
